Rare CNS Disorders

PsychoGenics offers specialized preclinical research services tailored to rare CNS disorders to drive your program forward. Leveraging our translational research expertise, broad range of tests and rodent models, and customized, collaborative approach, we offer superior preclinical research support for your program to address the unique challenges posed by these conditions.

Uncovering Novel Solutions

At PsychoGenics, our forward-leaning approach in preclinical CNS research is anchored in both traditional and innovative methods. This dual approach, backed by experience, enables identification of effects in our animal models, offering a comprehensive evaluation of your compound’s efficacy in the target rare disease.